Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Congrats to @Advaxis on the launch of their new online investor center - "
Except that there is NOTHING NEW to report.....
No Real Leader = No one to push milestones....
If I were Tony, why should I work hard when I know I will eventually be replaced.... enjoy the pay and free stocks
ADRO's got a nice premarket pop up of $1.20.... premarket volume is only 12 though lol
We're only discussing the science.... talking about PETX getting AT-014 conditional approval and the other company which AT-014 science belongs to....
This is the statistic that ADXS Phase 3 trail must beat? 50% recurrence?
High risk #CervicalCancer recurs in 50% of women, and there are clinical trial options that might help. Know your options! Visit clinicaltrials.gov
https://twitter.com/advaxis/status/954366442815807488
"Whomever has been manipulating the share price has done 10x whatever minor damage Dan caused."
Could Dan & Management have done something to thwart the short cartel? YES
Can Tony & Management do something to thwart the short cartel? YES
Ok short-term & and day-to-day stuff could be out of control... but letting the manipulation go for over 3 years is like a new Guinness World Record
"The rapporteurs for the AXAL MAA are Finland (not France) and Sweden."
Thanks for the correction Dew
Lol... speaking of which, ONCS short interest has been steadily increasing
12/29/2017 1,890,478
12/15/2017 1,874,653
11/30/2017 1,843,080
11/15/2017 1,809,968
10/31/2017 1,746,675
10/13/2017 575,924
Good post, unfortunately none of this is reflected in PERX share price....
"Merck and Pfizer, among many others use these guys, so why is it a problem that ADXS would?"
I'm not saying it's a problem... just trying to connect PX deal to EU Submission...
There was a post on this board stating that Noelle mentioned PX deal will help with ADXS-NEO stuff.... but could there be more to PX deal in terms of EU Submission?
"Even if the primary intent is ramping up NEO manufacturing, it also seems logical in the sense that a EU based company may also pay dividends if any questions arise out of the EU submission for AXAL."
Going from memory... The two rapporteurs for ADXS EU submission are France & Sweden.
PX Therapeutics is based in France.
The big Question Mark is why hire a Contract Development & Manufacturing Org (PX Therapeutics) in France (Europe)?
Why not hire someone close to home in USA? Link below is one example:
https://www.patheon.com/en-us/About-Us/Sites
PX Therapeutics case study on process development shows that it can reduce Cost of Goods and Speed up Manufacturing....
https://px-therapeutics.com/wp-content/uploads/2017/12/px-therapeutics-bioproduction-case-study-Process-development-process-optimization.pdf
"Just talked to Noelle and she said we hired them as consultants for the manufacturing for NEO. NEO is already being manufactured in NJ at Adxs`s facility,and PX is`nt manufacturing for us. I hope that calms down some here. GLTAL"
They couldn't find experts here in the US or Latin America or Canada, so they ended up getting a partnership in EU?
They can say whatever they want, French Consultant and EU Submission is giving out the smell of an EU Partnership at play.... IMHO
"PX Therapeutics is a contract manufacturing company, not a drug company per se."
Could this be a preview to EU Partnership? Similar in nature to AMGN deal where ADXS is in full control of Manufacturing?
Hornet, if you got a little more cash, would you buy more ADXS before Jan 19 puts expiration or after? Why?
"Interesting. French company. Could this be the beginning of a European blitz of info?"
Good observation, thanks.
"Who would bring a 20 offer to the table on a 3 company when they could take that offer to the shareholders directly?"
The same could have been said for the AMGN deal... who would bring $500 Million offer on the table for just one franchise when ADXS Market Cap was around $500 Million....
Yet AMGN deal happened.
Nonetheless, deal in play is still a speculation.... and so is another partnership... but a partnership could be more likely situation with upfront cash....
ADRO's been tanking recently... at $6.75 now
Warrants means more cash on hand, it would be in the best interest of the incompetent management to ensure that ADXS is above $5.... so that they can continue to pay themselves...
The only thing that needs firing and complete Change is ADXS BOD...
If they have a plan and they want to strategically stay quiet... ok fair enough...
But history tells us they they are POS!
Agreed.
I'm hopeful as this is still a possibility, but this would be putting too much faith in the incompetent ADXS Management..... BOD needs a complete makeover of that doesn't turn out to be the case
Could be just me, but I'm having bad experience getting responses from ADXS IR... first I had left a voice message a few months back, no reply... and around last week I got a generic response of 4 cancer franchises...
Maybe it's because I'm asking questions with the keyword "shareholder value" and I'm put on ignore....
IMO, good leadership is of most importance right now...
Must have a CMO and CEO
EU Submission target is Q1 2018....
Expecting any more than that from ADXS Management will only result in disappointment..... as they have a track record of missing every milestone of 2H 2017
Hey Terry,
What do you think of a possible sale in the works? Could it be a high probability or just a speculation in your opinion?
Thanks
Agreed
You have to look at the fundamentals and ADXS will eventually rise to its fundamentals...
1. Science works: first proof is ADXS GOG best historical results, and second proof is AT-014 conditional approval
2. Second is financial... there maybe a panic that ADXS could run out of money, but as of today... ADXS can go atleast 3 more quarters and has $0 debt. Also, ADXS has $1 billion in partnership progress payments thru AMGN & SELLAS
3. The best fundamental is that ADXS has 4 cancer franchises and none of that value is reflected in the current price.
IMO, the real problem is that ADXS lacks a real leader (CEO) and a good CMO. This is all due to Management's incompetence, however, there is a possibility that a sale may be in the works (PURE SPECULATION, but still a possibility).
This article is biased and rookie minded...
Don't get me wrong, as I am a biotech rookie myself... but some of the explanations are one sided bias...
Thanks, I found that article also, but wasn't sure if that is the specific number of warrants...
"True. There is always an overallotment, because the underwriters use the Greenshoe Option and short the shares. So that explains it."
Can you please explain this in simple words?
Does anyone know the count of ADXS Warrants? How would I find out?
ADXS Phase 3 trail website, not sure if it's been posted:
https://aim2cerv.com/?utm_content=buffer09b0e&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer
Good post, thanks mortmann
Agreed, buyout is still a possibility, but IMO it gets super exaggerated on this board....
Sure one possibility is buyout.
Another possibility could be that all the corporations are in bonus and raises mode thanks to tax cuts... and ADXS is joining along to keep the talent from leaving.
Another possibility could be Management has no clue what April will be like so get your loot while you still can.
And so on....
Again, 100% Agreed!
"You are the one saying manipulation everyday. The onus is on you to show the proof. If you can’t, it’s just pure speculation, plain and simple."
If manipulation could be proved, SEC would grilling their a$$es....
Common sense observation can help deduce manipulation, but who doing it is the unknown..... FOR Example: if we knew who exactly is shorting ADXS, it could reveal manipulation
100% AGREED!
"I am guessing they added to the short position to knock the PPS back down when it jumped to $3.40"
Agreed, good observation
"Perhaps, it may elicit interest when it comes down to $1 but now, it looks dead beyond repair."
IMHO, ADXS is very repair, all we need is a competent CEO & CMO... and watch ADXS go $30+ within one year